Both familial Parkinson's disease mutations accelerate α-synuclein aggregation

被引:629
作者
Narhi, L [1 ]
Wood, SJ [1 ]
Steavenson, S [1 ]
Jiang, YJ [1 ]
Wu, GM [1 ]
Anafi, D [1 ]
Kaufman, SA [1 ]
Martin, F [1 ]
Sitney, K [1 ]
Denis, P [1 ]
Louis, JC [1 ]
Wypych, J [1 ]
Biere, AL [1 ]
Citron, M [1 ]
机构
[1] Amgen Inc, Thousand Oaks, CA 91320 USA
关键词
D O I
10.1074/jbc.274.14.9843
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Parkinson's disease (PD) is a neurodegenerative disorder that is pathologically characterized by the presence of intracytoplasmic Lewy bodies, the major component of which are filaments consisting of alpha-synuclein. Two recently identified point mutations in alpha-synuclein are the only known genetic causes of PD, but their pathogenic mechanism is not understood. Here we show that both wild type and mutant alpha-synuclein form insoluble fibrillar aggregates with antiparallel beta-sheet structure upon incubation at physiological temperature in vitro. Importantly, aggregate formation is accelerated by both PD-linked mutations. Under the experimental conditions, the lag time for the formation of precipitable aggregates is about 280 h for the wild type protein, 180 h for the A30P mutant, and only 100 h for the A53T mutant protein. These data suggest that the formation of alpha-synuclein aggregates could be a critical step in PD pathogenesis, which is accelerated by the PD-linked mutations.
引用
收藏
页码:9843 / 9846
页数:4
相关论文
共 16 条
  • [1] Baba M, 1998, AM J PATHOL, V152, P879
  • [2] Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease
    Conway, KA
    Harper, JD
    Lansbury, PT
    [J]. NATURE MEDICINE, 1998, 4 (11) : 1318 - 1320
  • [3] SECONDARY STRUCTURE OF THE PENTRAXIN FEMALE PROTEIN IN WATER DETERMINED BY INFRARED-SPECTROSCOPY - EFFECTS OF CALCIUM AND PHOSPHORYLCHOLINE
    DONG, A
    CAUGHEY, B
    CAUGHEY, WS
    BHAT, KS
    COE, JE
    [J]. BIOCHEMISTRY, 1992, 31 (39) : 9364 - 9370
  • [4] Neuropathology of Parkinson's disease
    Forno, LS
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (03) : 259 - 272
  • [5] Amyloid, the presenilins and Alzheimer's disease
    Hardy, J
    [J]. TRENDS IN NEUROSCIENCES, 1997, 20 (04) : 154 - 159
  • [6] SEEDING ONE-DIMENSIONAL CRYSTALLIZATION OF AMYLOID - A PATHOGENIC MECHANISM IN ALZHEIMERS-DISEASE AND SCRAPIE
    JARRETT, JT
    LANSBURY, PT
    [J]. CELL, 1993, 73 (06) : 1055 - 1058
  • [7] Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease
    Krüger, R
    Kuhn, W
    Müller, T
    Woitalla, D
    Graeber, M
    Kösel, S
    Przuntek, H
    Epplen, JT
    Schöls, L
    Riess, O
    [J]. NATURE GENETICS, 1998, 18 (02) : 106 - 108
  • [8] Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
    Lacey, DL
    Timms, E
    Tan, HL
    Kelley, MJ
    Dunstan, CR
    Burgess, T
    Elliott, R
    Colombero, A
    Elliott, G
    Scully, S
    Hsu, H
    Sullivan, J
    Hawkins, N
    Davy, E
    Capparelli, C
    Eli, A
    Qian, YX
    Kaufman, S
    Sarosi, I
    Shalhoub, V
    Senaldi, G
    Guo, J
    Delaney, J
    Boyle, WJ
    [J]. CELL, 1998, 93 (02) : 165 - 176
  • [9] Lewy F.H., 1912, Handbuch der Neurologie, P920
  • [10] PATHOLOGY AND BIOLOGY OF THE LEWY BODY
    POLLANEN, MS
    DICKSON, DW
    BERGERON, C
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1993, 52 (03) : 183 - 191